Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p10)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

271-320 of about 500 reports
Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  • $ 2 500
  • Industry report
  • September 2012
  • by Global Data

Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Summary GlobalData's new report, ?Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring ...

  • Industries : Pathology
  • Countries : Australia
Drug and Medication in Australia: Cephalon, Inc. ? Product Pipeline Review - H2 2011

Drug and Medication in Australia: Cephalon, Inc. ? Product Pipeline Review - H2 2011

  • $ 1 500
  • Industry report
  • September 2012
  • by Global Markets Direct

- Product Pipeline Review - H2 2011? provides a detailed overview on the Cephalon, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Drug and Medication in United States: Progen Pharmaceuticals Limited - Product Pipeline Review - Q4 2010

Drug and Medication in United States: Progen Pharmaceuticals Limited - Product Pipeline Review - Q4 2010

  • $ 1 500
  • Industry report
  • September 2012
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Pharmaceutical
  • Countries : Australia, World
Pharmaxis Limited - Product Pipeline Review - 2012

Pharmaxis Limited - Product Pipeline Review - 2012

  • $ 1 500
  • Industry report
  • September 2012
  • by Global Markets Direct

Pharmaxis Limited - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Pharmaxis Limited - Product Pipeline Review - 2012? provides data on the Pharmaxis Limited's ...

  • Industries : Pharmaceutical
  • Countries : World, United States, Australia
Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2012
  • by Business Monitor International

BMI View: Hong Kong was in the past an attractive commercial prospect, largely propped by the widespread use of patented medicines. However, the climate of cost-containment over the past decade represents ...

  • Industries : Drug and Medication
  • Countries : China, United States, Australia
Antibiotics Market in Australia to 2016

Antibiotics Market in Australia to 2016

  • $ 652
  • Industry report
  • September 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Australia. The study provides essential market information for decision-makers ...

  • Industries : Drug and Medication
  • Countries : Australia
MarketVIEW: Acne vaccines

MarketVIEW: Acne vaccines

  • $ 8 995
  • Industry report
  • September 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Acne vulgaris is a common skin condition which is estimated to affect 80% of people at some point between 11 and 30 years of age. The condition ranges from mild to severe with latter more likely to cause ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, Canada, Spain, Italy, France, Germany, Japan
Bronchitis - Pipeline Review, H2 2012

Bronchitis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Bronchitis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Bronchitis - Pipeline Review, H2 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : Australia, World
CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary CBio Limited ( CBio ) is a research focused biopharmaceutical company targeting on development of technologies fo ...

  • Industries : Pharmaceutical
  • Countries : Australia
Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Pharmacies and Drug Stores
  • Countries : Australia
Vitamins and Provitamins - Australia

Vitamins and Provitamins - Australia

  • $ 652
  • Industry report
  • July 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for vitamins and provitamins in Australia. The study provides essential market information fo ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
Australian Pharmaceutical Sector: Sector Report

Australian Pharmaceutical Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australian Drug Sector: Sector Report

Australian Drug Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Drug and Medication
  • Countries : Australia
MarketVIEW: Candida vaccines

MarketVIEW: Candida vaccines

  • $ 7 995
  • Industry report
  • July 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Candida yeasts cause Candidiasis which is a fungal infection commonly found in humans. Infections can occur in the female Genital area "vulvovaginal candidiasis" of which nearly 75% of all adult women ...

  • Industries : Drug and Medication
  • Countries : Australia, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, World
MarketVIEW: Herpes Simplex Virus (TX) vaccines

MarketVIEW: Herpes Simplex Virus (TX) vaccines

  • $ 8 995
  • Industry report
  • July 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Herpes Simplex Virus (HSV) is a sexually transmitted virus which is a major cause of genital herpes (GH). Although most individuals infected with HSV-2 have minimal signs of infection, the disease is life-long ...

  • Industries : Drug and Medication
  • Countries : United States, United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Kawasaki Disease - Pipeline Review, H1 2012

Kawasaki Disease - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Kawasaki Disease - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Kawasaki Disease - Pipeline Review, H1 2012', provides an overview of the Kawasaki Disease therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World, Australia
Mylan Inc. (MYL) : Company Profile and SWOT Analysis

Mylan Inc. (MYL) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • June 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Mylan Inc. (MYL) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Industries : Drug Delivery Technology
  • Countries : United States, World, New Zealand, Australia, Canada, Japan, India
Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis

Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • June 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a ...

  • Industries : Pathology
  • Countries : United States, World, Australia
Biogen Idec Inc. (BIIB) : Company Profile and SWOT Analysis

Biogen Idec Inc. (BIIB) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • June 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Biogen Idec Inc. (BIIB) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Pathology
  • Countries : United States, World, Australia, Canada, Japan
Biotrin International - Product Pipeline Analysis

Biotrin International - Product Pipeline Analysis

  • $ 750
  • Company report
  • June 2012
  • by Global Data

Biotrin International - Product Pipeline Analysis Summary Biotrin International (Biotrin) is a medical device company, based in Ireland. The company provides novel and proprietary tests for the clinician ...

  • Industries : Pathology
  • Countries : Czech Republic, Ireland, World, Australia, Argentina, Europe
Australian Drug Market Research

Australian Drug Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Drug and Medication
  • Countries : Australia
Asia Pacific Pharma Sector Analysis

Asia Pacific Pharma Sector Analysis

  • $ 1 300
  • Industry report
  • June 2012
  • by RNCOS

The Asia-Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. In the recent years, the demand for healthcare services has risen among the region's ...

  • Industries : Generic Drug
  • Countries : Asia, Philippines, South Korea, Australia, India, China, World, Thailand, Malaysia, Japan, New Zealand, Indonesia, Vietnam, Oceania
Australian Pharmaceutical Market Research

Australian Pharmaceutical Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Pharmaceutical
  • Countries : Australia
Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • May 2012
  • by ICD Research

Synopsis ICD Research's "Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Pharmacies and Drug Stores
  • Countries : United States, Australia, Mexico, Israel
Insulin - Australia

Insulin - Australia

  • $ 652
  • Industry report
  • May 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in Australia. The study provides essential market information for decision-makers ...

  • Industries : Drug and Medication
  • Countries : Australia
OSI Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

OSI Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2012
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Australia
OTC Pharmaceuticals - New Zealand (2011)

OTC Pharmaceuticals - New Zealand (2011)

  • $ 599
  • Industry report
  • April 2012
  • by Mintel

OTC Pharmaceuticals in New Zealand by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers OTC pharmaceuticals, that is, ...

  • Industries : Over-the-counter Drug
  • Countries : New Zealand
Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report

Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • April 2012
  • by Canadean Ltd

Synopsis Canadean's "Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Pharmacies and Drug Stores
  • Countries : Australia
MarketVIEW - Staphylococcus aureus vaccines

MarketVIEW - Staphylococcus aureus vaccines

  • $ 9 995
  • Industry report
  • April 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-positive Staphylococcus aureus is an opportunistic pathogen and a major cause of patient morbidity and mortality, especially in "at risk" populations. The organism can cause a wide range of infections ...

  • Industries : Drug and Medication
  • Countries : United States, France, Germany, Europe, Australia, Canada, United Kingdom, Spain, Italy, Japan, World
Halcygen Pharmaceuticals Limited (MYX) - Financial and Strategic SWOT Analysis Review

Halcygen Pharmaceuticals Limited (MYX) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Halcygen Pharmaceuticals Limited (Halcygen) is focused on the improvement and reformulation of existing drugs. The company has two products under development which include SUBA-itraconazole and Minocycline. ...

  • Industries : Drug and Medication
  • Countries : Australia

» Read our Company Profiles

13 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Medtronic Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.